Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.02% rose 2.55% to $79.18 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +4.41% rising 0.02% to 13,542.12 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.18% falling 0.38% to 34,168.09. The stock's rise snapped a 10-day losing streak. Novavax Inc. closed $252.50 below its 52-week high ($331.68), which the company achieved on February 9th.
The stock outperformed some of its competitors Wednesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +4.07% fell 4.40% to $19.79, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -6.79% fell 6.36% to $1.62, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB -1.07% fell 3.35% to $31.41. Trading volume (8.1 M) eclipsed its 50-day average volume of 6.2 M.